VIDAC PHARMA HOLDING PLC
Climate Impact & Sustainability Data (2022-2033e, 2023)
Reporting Period: 2022-2033e
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Accumulated losses of more than GBP 24.7 mn
- Risks from upscaling the business model
- High complexity of organisational growth
- Translation risks from currency translation
- Dependence on reimbursement, including from public health authorities and private health insurers
- Uncertainty over approval
- Competition with well-funded companies
- Listing on the unregulated OTC market
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: IFRS
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Employee well-being
- Environmental responsibility (low energy consumption)
- Responsible business conduct
Social Achievements
- Implemented development and training programs for employees, creating a safe and motivating work environment. Increased investment in professional development and employee well-being to support their motivation and productivity. Initiatives were developed and implemented to improve work-life balance and promote healthy living.
Governance Achievements
- Established an organisational structure with clear reporting procedures, lines of responsibility, and delegated authority, in line with the group’s governance framework, which the Board reviews regularly.
Climate Goals & Targets
Environmental Challenges
- Clinical Drug Development Uncertainty
- Patent Protection Compliance
- Regulatory and Manufacturing Challenges
- Ongoing Operating Losses
- Financing Challenges
Mitigation Strategies
- Conduct thorough preclinical studies.
- Implement robust project management.
- Diversify the product pipeline.
- Secure partnerships to share costs and risks.
- Establish a dedicated patent management team.
- Implement a patent tracking system.
- Engage experienced patent attorneys.
- Regularly audit patent processes.
- Develop a comprehensive regulatory strategy.
- Maintain open communication with regulatory bodies.
- Hire regulatory experts.
- Invest in quality assurance systems.
- Establish contingency plans.
- Monitor and manage operational expenses.
- Focus on milestone achievements.
- Explore diverse revenue streams.
- Implement cost-saving initiatives.
- Develop a comprehensive financing strategy.
- Maintain strong investor relationships.
- Demonstrate clear milestones to attract investment.
- Explore strategic partnerships.
- Implement robust cash flow management.